As the Fed meets and earnings news rains down, the big question in the week ahead is whether the S&P 500 can manage a break out.» Read More
Mark Luschini, Janney Montgomery Scott, and David Darst, Morgan Stanley Wealth Management, provide their investment strategies for the next six months, as the markets face a slew of challenges, including a possible pullback in the Fed's asset-buying program.
Ashwani Kaul, Kaul Advisory Group, provides his projections on which sectors will likely prove to be the real earnings bright spots in the second quarter.
Tim Holland, TAMRO Capital, provides a preview of Friday's employment report and weighs in on how Fed policy will likely impact the markets.
CNBC's Ross Westgate tells you what the markets will be watching as we approach the start of trading in the U.S.
Are the markets in a super-bull cycle? Liz Ann Sonders, Charles Schwab; Jeff Kilburg, KKM Financial; Jeremy Siegel, Wharton Finance professor; and Zane Brown, Lord Abbett, share their opinions.
Mad Money host Jim Cramer shares his final thoughts of the day.
Catching up on biotech stocks Trius Therapeutics, Array Biopharma and Cytokinetics, with Mad Money host Jim Cramer.
Onyx Pharmaceuticals is seeking out more competitive offers beyond Amgen's $10 billion takeover bid. "Mad Money" host Jim Cramer says there are better opportunities in the biotech space right now.
Casual restaurant Noodles & Co. currently operates 343 restaurants, 52 of which are franchised. Mad Money host Jim Cramer says the company is very well run, but that investors should wait for a market pullback before buying.
Mad Money host Jim Cramer takes viewers behind the scenes of today's market rally.
"Fast Money" traders explains why he has moved on from Louisiana-Pacific; and how to play Sirius XM Radio and other stocks requested on Twitter.
Fast forwarding to Tuesday's trades, with the "Fast Money" traders. June auto sales data is out tomorrow, and Constellation Brands will reports its Q1 earnings.
Gold posted its sharpest quarterly decline on record in Q2. Dennis Gartman of The Gartman Letter, explains why he is bullish on the commodity; and Harvey Kanter, Blue Nile CEO, discusses how jewelry retailers are faring amid falling prices.
The emerging markets ETF is continuing its impressive 5-day winning streak, with the "Fast Money" traders; Barbara Ryan, FTI Consulting, discusses Onyx Pharmaceuticals' decision to reject a bid from Amgen, and opportunities in the biotech industry now.
Eyeing Tuesday's trading session, with Michael Underhill, Capital Innovations CIO; Chris Lecerenza, Russell & Co.; and Oliver Pursche, Gary Goldberg Financial Services.
Breaking down the factors affecting gold and stocks, with James Rickards of Tangent Capital and Lee Munson of Portfolio Asset Management.
Can the strong rally continue in the second half? Danielle Hughes of Divine Capital, Erik Ristuben at Russell Investments, Wasif Latif at USAA Investments and CNBC's Rick Santelli discuss.
CNBC's Sharon Epperson discusses the day's activity in the commodities markets. Gold rebounded today, and copper was up, as well.
Dissecting today's market action ahead of the close, with Brian Belski, BMO Capital Markets, and Chris Hyzy, U.S. Trust.
Is the Fed overestimating the strength of the U.S. consumer? Dean Baker, Center For Economic and Policy Research; Andrew Wilkinson, Miller Tabak & Co.; and CNBC's Rick Santelli, discuss.